Cappellini, M. Et Al. 2017. Efficacy and Safety of Deferasirox Across Underlying Non-Transfusion-Dependent Thalassemia Syndromes: 1-Year Results From the THETIS Study. Annual Meeting of the Society-for-the-Advancement-of-Blood-Management , (Oregon, United States Of America), 1-2.

Cappellini, M., Viprakasit, V., AYDINOK, Y., Porter, J., Lai, Y., Siritanaratkul, N., ... KARAKAŞ, Z.(2017). Efficacy and Safety of Deferasirox Across Underlying Non-Transfusion-Dependent Thalassemia Syndromes: 1-Year Results From the THETIS Study . Annual Meeting of the Society-for-the-Advancement-of-Blood-Management (pp.1-2). Oregon, United States Of America

Cappellini, M. Et Al. "Efficacy and Safety of Deferasirox Across Underlying Non-Transfusion-Dependent Thalassemia Syndromes: 1-Year Results From the THETIS Study," Annual Meeting of the Society-for-the-Advancement-of-Blood-Management, Oregon, United States Of America, 2017

Cappellini, M. Et Al. "Efficacy and Safety of Deferasirox Across Underlying Non-Transfusion-Dependent Thalassemia Syndromes: 1-Year Results From the THETIS Study." Annual Meeting of the Society-for-the-Advancement-of-Blood-Management , Oregon, United States Of America, pp.1-2, 2017

Cappellini, M. Et Al. (2017) . "Efficacy and Safety of Deferasirox Across Underlying Non-Transfusion-Dependent Thalassemia Syndromes: 1-Year Results From the THETIS Study." Annual Meeting of the Society-for-the-Advancement-of-Blood-Management , Oregon, United States Of America, pp.1-2.

@conferencepaper{conferencepaper, author={M. Cappellini Et Al. }, title={Efficacy and Safety of Deferasirox Across Underlying Non-Transfusion-Dependent Thalassemia Syndromes: 1-Year Results From the THETIS Study}, congress name={Annual Meeting of the Society-for-the-Advancement-of-Blood-Management}, city={Oregon}, country={United States Of America}, year={2017}, pages={1-2} }